Impact of the COVID-19 lockdown on patients and families with Dravet syndrome.


Journal

Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036

Informations de publication

Date de publication:
03 2021
Historique:
received: 31 07 2020
revised: 19 12 2020
accepted: 28 12 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 9 3 2021
Statut: epublish

Résumé

We explored the impact of coronavirus virus 2019 (COVID-19) pandemic on patients with Dravet syndrome (DS) and their family. With European patient advocacy groups (PAGs), we developed an online survey in 10 languages to question health status, behavior, personal protection, and health services before and after lockdown. Approximately 538 European PAG members received electronic invitations. Survey ran from April 14, to May 17, 2020, with 219 answers; median age 9 year 10 months. Protection against infection was highly used prior to COVID-19, but 88% added facemask-use according to pandemic recommendations. Only one patient was tested positive for COVID-19. Most had stable epilepsy during lockdown, and few families (4%) needed emergency care during lockdown. However, behavior disorder worsened in over one-third of patients, regardless of epilepsy changes. Half of appointments scheduled prior to lockdown were postponed; 12 patients (11%) had appointments fulfilled; and 39 (36%) had remote consultations. Responders welcomed remote consultations. Half of responders were unsatisfied with psychological remote support as only few (21 families) received this support. None of the five of patient in clinical trials stopped investigational treatment. Prior adoption of protective measures against general infection might have contributed to avoiding COVID-19 infections. Protocols for the favored remote contact ought to now be prepared.

Identifiants

pubmed: 33681664
doi: 10.1002/epi4.12464
pmc: PMC7918338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

216-224

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Déclaration de conflit d'intérêts

The authors have nothing to declare in relation to this manuscript. This manuscript did not receive any additional fund. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Références

Epilepsia. 2011 Apr;52 Suppl 2:50-4
pubmed: 21463280
Epilepsia. 2011 Apr;52 Suppl 2:3-9
pubmed: 21463272
Epilepsia. 2015 Apr;56(4):e36-9
pubmed: 25778844
Epilepsia. 2020 Jun;61(6):1312-1314
pubmed: 32420620
Epilepsia. 2020 Jun;61(6):1166-1173
pubmed: 32353184
Epilepsia. 2019 Dec;60 Suppl 3:S17-S24
pubmed: 31904117
Epilepsy Behav. 2020 Jul;108:107094
pubmed: 32375095
Dev Med Child Neurol. 2015 Jul;57(7):628-633
pubmed: 25772213
Pediatrics. 2015 Nov;136(5):e1310-5
pubmed: 26438699
Dev Med Child Neurol. 2018 Jan;60(1):63-72
pubmed: 28984349
Rev Neurol. 2019 Jan 16;68(2):75-81
pubmed: 30638257

Auteurs

Isabella Brambilla (I)

Dravet Italia Onlus, Milano, Italy.
Research Center for Pediatric Epilepsies Verona, Verona, Italy.

José Ángel Aibar (JÁ)

Dravet Syndrome Foundation Spain, Madrid, Spain.

Anne Sophie Hallet (AS)

Alliance Syndrome de Dravet, Malesherbes, France.

Irena Bibic (I)

Dravet Sindrom Hrvatska, Split, Croatia.

Elena Cardenal-Muñoz (E)

Dravet Syndrome Foundation Spain, Madrid, Spain.

Igor Prpic (I)

Department of Child Neurology, Medical Faculty, Referral Center for Childhood Epilepsy and Convulsive Disorders, University Hospital Rijeka, University of Rijeka, Rijeka, Croatia.

Francesca Darra (F)

Research Center for Pediatric Epilepsies Verona, Verona, Italy.
Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.

Nicola Specchio (N)

Rare and Complex Epilepsy Unit, Department of Neuroscience, Member of European Reference Network EpiCARE, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Rima Nabbout (R)

Centre de Référence Épilepsies Rares, Necker Enfants MaladesUniversity Hospital, Department of Pediatric Neurology, Member of EPICARE European Reference Network Epicare, Institut Imagine, U1163, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH